The development of monoclonal antibodies to block the action of NGF (Zoetis sponsored symposium)

British Small Animal Veterinary Association , e164 (2021); https://doi.org/10.22233/9781913859008.164

/content/chapter/10.22233/9781913859008.Ch164

fThe development of monoclonal antibodies to block the action of NGF (Zoetis sponsored symposium)

Speaker: John Innes
From: BSAVA Congress Proceedings 2021
Stream: Sponsored symposia
Lecture Type: For the practice team
DOI: 10.22233/9781913859008.164
Copyright: © 2021 British Small Animal Veterinary Association
First broadcast: May 2021

Previous Lecture
Table of Contents
Next Lecture

Abstract

This presentation reviews the role of NGF in joint pain, provides an overview of the medications that have been available for osteoarthritis (OA) pain over the past 30 years and moves on to introduce anti-NGF monoclonal antibody as a new therapeutic class for the management of OA pain.

Full text loading...

/content/chapter/10.22233/9781913859008.Ch164

Supplements

Loading ...